Type 2 diabetes and cancer: what is the connection?
Cannata
Dara
D
Mount Sinai School of Medicine, New York, NY, USA.
Fierz
Yvonne
Y
Vijayakumar
Archana
A
LeRoith
Derek
D
D001943:Breast Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D006801:Humans; D006946:Hyperinsulinism; D007328:Insulin; D007333:Insulin Resistance; D008297:Male; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D018570:Risk Assessment; D012307:Risk Factors; D013002:Somatomedins; D045162:Thiazolidinediones / Q000627:therapeutic use
D007328:Insulin; D013002:Somatomedins; D045162:Thiazolidinediones